Refine by region/country
Latest articles in Health Care
Equity Analysis / Global

SEARL enters exclusive license agreement with Beximco Pharma for Remdesivir

In an exchange filing today, SEARL PA has announced that it has successfully entered into a licensing and marketing agreement with Beximco Pharmaceuticals Bangladesh for Remdesivir – a US FDA approved wide-spectrum antiviral drug used to treat...
Intermarket Securities Yusra Beg
Yusra Beg @ Intermarket Securities 29 May 2020
SEARL enters exclusive license agreement with Beximco Pharma for Remdesivir
Equity Analysis / Pakistan

Pakistan's Ferozsons enters negotiations for Remdesivir production

In an exchange filing yesterday, Ferozsons Laboratories Limited (FEROZ) notified that it has entered negotiations, via its 80% owned subsidiary BF Biosciences Limited (BFBL), to potentially reach a non-exclusive license agreement with US-based Gilead...
Intermarket Securities Yusra Beg
Yusra Beg @ Intermarket Securities 12 May 2020
Equity Analysis / Pakistan

Pakistan: Ferozsons in talks with Gilead to produce Covid-19 drug Remdesivir

BF Biosciences limited, a subsidiary of Ferozsons Laboratories (FEROZ PA), is in talks with Gilead Sciences to manufacture and supply Remdesivir, a drug approved by the FDA to tread Covid-19 patients in critical condition, to Pakistan and 126 other c...
Tellimer Research Vahaj Ahmed
Vahaj Ahmed @ Tellimer Research 11 May 2020
Pakistan: Ferozsons in talks with Gilead to produce Covid-19 drug Remdesivir
Flash Report / Bangladesh

Square to set up a new subsidiary

Square plans to invest BDT3.5bn (cUSD41mn) to set up a fully-owned pharmaceuticals subsidiary named Square Lifesciences Limited, according to a news release on the Dhaka Stock Exchange. The subsidiary will manufacture oral solid dosage products to me...
IDLC Securities Tanay Kumar Roy
Tanay Kumar Roy @ IDLC Securities 18 February 2020
Strategy Note / Saudi Arabia

2020 Saudi Equity Strategy

We expect 2020 to be a more positive year for the Saudi economy, with stronger growth driven by the non-oil sector as a result of progress on the Vision Realisation Programs (VRPs) and the domestic investment of the proceeds of the Saudi Aramco...
NCB Capital Irfan Ellam
Irfan Ellam @ NCB Capital 20 January 2020
Equity Analysis / Vietnam

Vietnam 2020 investment strategy

In our 145-page strategy report we cover all angles of the Vietnam investment case in 2020. Top-down, we highlight the global and domestic macro drivers, as well as upcoming index changes as Vietnam becomes a dominant weight in FM indices. Botto...
Rong Viet Tu Vu
Tu Vu @ Rong Viet 31 December 2019